D010778

3 trials

Sponsors

Endo Toshiki, Usuda Jitsuo, Miyake Masahiro

Conditions

Peripheral Lung Cancer Lung Cancercentral serous chorioretinopathy central serous chorioretinopathy, CSC,spinal cord malignant tumor Malignancy

Phase 2

A randomized controlled trial of best supportive care (BSC) versus photodynamic therapy with ME2906 and PNL6405PLC for patients with peripheral lung cancer

Active, not recruitingJPRN-jRCT2031200040

Usuda JitsuoPeripheral Lung Cancer Lung Cancer

Start: 2020-06-03Target: 50Updated: 2026-06-29

Multi-institutional phase II study of photodynamic therapy using ME2906 and PNL6405SCT for patients with malignant spinal cord tumor.

Active, not recruitingJPRN-jRCT2021220040

Endo Toshikispinal cord malignant tumor Malignancy

Start: 2023-01-12Target: 20Updated: 2026-06-29

Phase 3

Reduced-fluence Photodynamic Therapy versus Placebo for Central Serous Chorioretinopathy

RecruitingJPRN-jRCT2051230156

Miyake Masahirocentral serous chorioretinopathy central serous chorioretinopathy, CSC,

Start: 2023-12-26Target: 70Updated: 2026-06-29

Related Papers

Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial.

2026-04-21

First-in-Human Trial of Photodynamic Therapy for Spinal Cord Malignant Astrocytoma: Study Protocol

Neurospine2024-12-30